{"symbol":"ABT","fiscalQuarter":"Q4-2015","reportDate":"2016-01-28","reportTime":"BMO","status":"reported","company":{"name":"Abbott Laboratories","sector":"Health Care","industry":"Health Care Equipment"},"tier":"free","webUrl":"https://earningsnxt.ai/ticker/ABT/earnings/Q4-2015","postBrief":{"headline":"Abbott Laboratories Beats on EPS, Stock Down 9.3%","keyNumbers":[{"metric":"EPS","actual":"$0.62","expected":"N/A","surprise":"+1.31%"},{"metric":"Revenue","actual":"N/A","expected":"N/A","surprise":"N/A"}],"managementCommentary":{"tone":"Unknown","keyQuotes":[],"summary":"No transcript is on record, and the analysis is based solely on numerical results."},"guidanceChanges":{"summary":"No forward guidance data is available.","changes":[]},"whatItMeans":"Abbott Laboratories reported an EPS of $0.62, slightly beating expectations. However, the stock fell by 9.3%, indicating investor concerns despite the earnings beat. The lack of revenue data and management commentary may have contributed to the negative stock reaction.","metaDescription":"Abbott Laboratories (ABT) Q4 2015 earnings: EPS beat by 1.31%. Stock down 9.3%. Full breakdown."}}